NADAC acquisition cost data for WEGOVY 2.4 MG/0.75 ML PEN. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00169452414 | $431.80 | 2022-07-20 | Rx |
| 00169452414 | $431.80 | 2022-07-20 | Rx |
| 00169452414 | $431.80 | 2022-07-20 | Rx |
| 00169452414 | $431.80 | 2022-07-20 | Rx |
| 00169452414 | $431.80 | 2022-07-20 | Rx |
| 00169452414 | $431.80 | 2022-07-20 | Rx |
| 00169452414 | $431.80 | 2022-07-20 | Rx |
| 00169452414 | $431.80 | 2022-07-20 | Rx |
| 00169452414 | $431.80 | 2022-07-20 | Rx |
| 00169452414 | $431.80 | 2022-07-20 | Rx |
Generic: Semaglutide | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A |
| 2023 | $199.8K | 142 | 47 | $496.25 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| Rhode Island | $142.4K | 100 | 28 |
| Pennsylvania | $25.1K | 19 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.